213 related articles for article (PubMed ID: 38772282)
1. Akt and AMPK activators rescue hyperexcitability in neurons from patients with bipolar disorder.
Khayachi A; Abuzgaya M; Liu Y; Jiao C; Dejgaard K; Schorova L; Kamesh A; He Q; Cousineau Y; Pietrantonio A; Farhangdoost N; Castonguay CE; Chaumette B; Alda M; Rouleau GA; Milnerwood AJ
EBioMedicine; 2024 Jun; 104():105161. PubMed ID: 38772282
[TBL] [Abstract][Full Text] [Related]
2. Focal adhesion is associated with lithium response in bipolar disorder: evidence from a network-based multi-omics analysis.
Niemsiri V; Rosenthal SB; Nievergelt CM; Maihofer AX; Marchetto MC; Santos R; Shekhtman T; Alliey-Rodriguez N; Anand A; Balaraman Y; Berrettini WH; Bertram H; Burdick KE; Calabrese JR; Calkin CV; Conroy C; Coryell WH; DeModena A; Eyler LT; Feeder S; Fisher C; Frazier N; Frye MA; Gao K; Garnham J; Gershon ES; Goes FS; Goto T; Harrington GJ; Jakobsen P; Kamali M; Kelly M; Leckband SG; Lohoff FW; McCarthy MJ; McInnis MG; Craig D; Millett CE; Mondimore F; Morken G; Nurnberger JI; Donovan CO; Øedegaard KJ; Ryan K; Schinagle M; Shilling PD; Slaney C; Stapp EK; Stautland A; Tarwater B; Zandi PP; Alda M; Fisch KM; Gage FH; Kelsoe JR
Mol Psychiatry; 2024 Jan; 29(1):6-19. PubMed ID: 36991131
[TBL] [Abstract][Full Text] [Related]
3. Neurons derived from patients with bipolar disorder divide into intrinsically different sub-populations of neurons, predicting the patients' responsiveness to lithium.
Stern S; Santos R; Marchetto MC; Mendes APD; Rouleau GA; Biesmans S; Wang QW; Yao J; Charnay P; Bang AG; Alda M; Gage FH
Mol Psychiatry; 2018 Jun; 23(6):1453-1465. PubMed ID: 28242870
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids.
Osete JR; Akkouh IA; Ievglevskyi O; Vandenberghe M; de Assis DR; Ueland T; Kondratskaya E; Holen B; Szabo A; Hughes T; Smeland OB; Steen VM; Andreassen OA; Djurovic S
Mol Psychiatry; 2023 Jul; 28(7):3033-3043. PubMed ID: 36653674
[TBL] [Abstract][Full Text] [Related]
5. Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients.
Santos R; Linker SB; Stern S; Mendes APD; Shokhirev MN; Erikson G; Randolph-Moore L; Racha V; Kim Y; Kelsoe JR; Bang AG; Alda M; Marchetto MC; Gage FH
Mol Psychiatry; 2021 Jun; 26(6):2440-2456. PubMed ID: 33398088
[TBL] [Abstract][Full Text] [Related]
6. Neural progenitor cells derived from lithium responsive and non-responsive bipolar disorder patients exhibit distinct sensitivity to cell death following methamphetamine.
Mishra HK; Mandyam AD; Trenet W; Wei H; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Gershon E; McInnis MG; ; Kelsoe JR; McCarthy MJ
Neuropharmacology; 2023 Mar; 226():109410. PubMed ID: 36608815
[TBL] [Abstract][Full Text] [Related]
7. Lithium-related genetics of bipolar disorder.
Detera-Wadleigh SD
Ann Med; 2001 May; 33(4):272-85. PubMed ID: 11405549
[TBL] [Abstract][Full Text] [Related]
8. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
[No Abstract] [Full Text] [Related]
9. Circadian rhythms in bipolar disorder patient-derived neurons predict lithium response: preliminary studies.
Mishra HK; Ying NM; Luis A; Wei H; Nguyen M; Nakhla T; Vandenburgh S; Alda M; Berrettini WH; Brennand KJ; Calabrese JR; Coryell WH; Frye MA; Gage FH; Gershon ES; McInnis MG; Nievergelt CM; Nurnberger JI; Shilling PD; Oedegaard KJ; Zandi PP; ; Kelsoe JR; Welsh DK; McCarthy MJ
Mol Psychiatry; 2021 Jul; 26(7):3383-3394. PubMed ID: 33674753
[TBL] [Abstract][Full Text] [Related]
10. Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder.
Mishra HK; Wei H; Rohr KE; Ko I; Nievergelt CM; Maihofer AX; Shilling PD; Alda M; Berrettini WH; Brennand KJ; Calabrese JR; Coryell WH; Frye M; Gage F; Gershon E; McInnis MG; Nurnberger J; Oedegaard KJ; Zandi PP; Kelsoe JR; McCarthy MJ
Eur Neuropsychopharmacol; 2023 Sep; 74():1-14. PubMed ID: 37126998
[TBL] [Abstract][Full Text] [Related]
11. Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients.
McCarthy MJ; Wei H; Landgraf D; Le Roux MJ; Welsh DK
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1310-9. PubMed ID: 27216486
[TBL] [Abstract][Full Text] [Related]
12. Lithium-responsive genes and gene networks in bipolar disorder patient-derived lymphoblastoid cell lines.
Breen MS; White CH; Shekhtman T; Lin K; Looney D; Woelk CH; Kelsoe JR
Pharmacogenomics J; 2016 Oct; 16(5):446-53. PubMed ID: 27401222
[TBL] [Abstract][Full Text] [Related]
13. Lithium response in bipolar disorder correlates with improved cell viability of patient derived cell lines.
Paul P; Iyer S; Nadella RK; Nayak R; Chellappa AS; Ambardar S; Sud R; Sukumaran SK; Purushottam M; Jain S; ; Viswanath B
Sci Rep; 2020 May; 10(1):7428. PubMed ID: 32366893
[TBL] [Abstract][Full Text] [Related]
14. Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder.
Machado-Vieira R; Zanetti MV; Teixeira AL; Uno M; Valiengo LL; Soeiro-de-Souza MG; Oba-Shinjo SM; de Sousa RT; Zarate CA; Gattaz WF; Marie SK
Eur Neuropsychopharmacol; 2015 Apr; 25(4):468-73. PubMed ID: 25726893
[TBL] [Abstract][Full Text] [Related]
15. Transcriptomics and miRNomics data integration in lymphoblastoid cells highlights the key role of immune-related functions in lithium treatment response in Bipolar disorder.
Cattane N; Courtin C; Mombelli E; Maj C; Mora C; Etain B; Bellivier F; Marie-Claire C; Cattaneo A
BMC Psychiatry; 2022 Oct; 22(1):665. PubMed ID: 36303132
[TBL] [Abstract][Full Text] [Related]
16. Cellular models to study bipolar disorder: A systematic review.
Viswanath B; Jose SP; Squassina A; Thirthalli J; Purushottam M; Mukherjee O; Vladimirov V; Patrinos GP; Del Zompo M; Jain S
J Affect Disord; 2015 Sep; 184():36-50. PubMed ID: 26070045
[TBL] [Abstract][Full Text] [Related]
17. Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder.
Cruceanu C; Alda M; Grof P; Rouleau GA; Turecki G
PLoS One; 2012; 7(2):e32680. PubMed ID: 22384280
[TBL] [Abstract][Full Text] [Related]
18. Lithium and suicide prevention in bipolar disorder.
Benard V; Vaiva G; Masson M; Geoffroy PA
Encephale; 2016 Jun; 42(3):234-41. PubMed ID: 27000268
[TBL] [Abstract][Full Text] [Related]
19. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
20. Lithium reduces the span of G protein-activated K
Dascal N; Rubinstein M
Bipolar Disord; 2017 Nov; 19(7):568-574. PubMed ID: 28895268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
